Table 1.
Cell lines used in studies with supramolecular nanomachines
| Cell line | Description | Drug delivered | Reference |
|---|---|---|---|
| MDA-MB-231 | human breast cancer cells | doxorubicin | 25 |
| MiaPaCa‐2 | human pancreatic cancer cells | doxorubicin | 34 |
| THP-1 and KB-31 |
THP-1: human differentiated leukemia monocytes KB-31: human squamous carcinoma cells |
doxorubicin | 36 |
| MDM and THP-1 |
MDM: human monocyte-derived macrophages THP-1: human differentiated leukemia monocytes (macrophage-like cells) |
moxifloxacin | 37 |
| L929 | murine aneuploidy fibrosarcoma cells | N/A | 52 |
| A549 | adenocarcinomic human alveolar basal epithelial cells | doxorubicin | 53 |
| PANC-1 | human pancreatic cancer cells | doxorubicin | 62 |
| HeLa and COS7 | HeLa: human cervical cancer cells COS7: African green monkey SV40-transformed kidney fibroblast cells |
doxorubicin | 66 |